Glaukos Corp (GKOS) — Technical state
As of 2026-10-30 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.
The Closelooknet read
- Closelooknet score: 50 out of 100 (momentum 94 · quality 25 · valuation 19), as of 2026-11-01.
- Signal: Uptrend stack intact — Trades +37.1% vs the 50-day and +68% vs the 200-day average, 4.5% below the 52-week high and +193.7% off the 52-week low. Computed from daily closes. (as of 2026-10-30)
- Trend: Glaukos Corp trades 37.1% above its 50-day and 68.0% above its 200-day moving average. (as of 2026-10-30)
Glaukos develops and sells devices and drug therapies for eye disease, with its core work centred on glaucoma. Its main products are the iStent and iStent infinite micro-bypass devices, which open natural drainage channels to relieve pressure inside the eye, alongside iDose TR, an implant that releases pressure-lowering medicine over time.
The full read — the desk's view, the earnings record, peers and the company snapshot — is on the GKOS overview. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.
Trades +37.1% vs the 50-day and +68% vs the 200-day average, 4.5% below the 52-week high and +193.7% off the 52-week low. Computed from daily closes.
The moving-average stack
- vs 20-day+33.8%
- vs 50-day+37.1%
- vs 200-day+68%
- 52-week band4.5% off the high · +193.7% off the low
- Streak1 consecutive down session
- 50-day crossprice crossed up through the 50-day 8 sessions ago
- Stochastic%K 87 · %D 87.8 · bear cross
Continue: the GKOS chart & overview · quality & forensics · the earnings record · the signal board
FAQ · from the current data · as of 2026-10-30
Quick answers
What is the current Closelooknet signal on GKOS?
Uptrend stack intact — Trades +37.1% vs the 50-day and +68% vs the 200-day average, 4.5% below the 52-week high and +193.7% off the 52-week low. Computed from daily closes. As of 2026-10-30; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.
Is GKOS above its 50-day and 200-day moving averages?
As of 2026-10-30, Glaukos Corp trades +37.1% above its 50-day and +68% above its 200-day average, with the 20-day +33.8% away.
How far is GKOS from its 52-week high?
4.5% below the 52-week high and 193.7% above the 52-week low, as of 2026-10-30.
Related in the Closelooknet universe
then Medical Devices. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- DXCM DexCom Incindustry
- GMED Globus Medicalindustry
- SNN Smith & Nephew SNATS Incindustry
- CEVI.ST CellaVision ABindustry
- SOON.SW Sonova H Agindustry
- SYK Stryker Corporationindustry
- PACB Pacific Biosciences of Californiaindustry
- QSI QuantumSi Incindustry
- SECT-B.ST Sectra AB (publ)industry
- AXGN Axogen Incindustry
- DEMANT.CO Demant A/Sindustry
- MED.SW Medartis Holding AGindustry
- 300760.SHE Shenzhen Mindray Bio-Medical Electronics Co Ltd Class Aindustry
- HAE Haemonetics Corporationindustry
- SHL.DE Siemens Healthineers AGindustry
- IRTC iRhythm Technologies Incindustry
- TNDM Tandem Diabetes Care Incindustry
- PHG Koninklijke Philips NV ADRindustry
- MDT Medtronic PLCindustry
- EW Edwards Lifesciences Corpindustry